Novel BP Agent Shows Clinical Promise
CHICAGO—Aliskiren, the first in a new class of direct renin inhibitors, is a useful adjunct to other antihypertensive agents for patients with mild to moderate hypertension, data suggest.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.